• Medientyp: E-Artikel
  • Titel: Molecular characterization of AIFM2/FSP1 inhibition by iFSP1-like molecules
  • Beteiligte: Xavier da Silva, Thamara Nishida; Schulte, Clemens; Alves, Ariane Nunes; Maric, Hans Michael; Friedmann Angeli, José Pedro
  • Erschienen: Springer Science and Business Media LLC, 2023
  • Erschienen in: Cell Death & Disease, 14 (2023) 4
  • Sprache: Englisch
  • DOI: 10.1038/s41419-023-05787-z
  • ISSN: 2041-4889
  • Entstehung:
  • Anmerkungen:
  • Beschreibung: <jats:title>Abstract</jats:title><jats:p>Ferroptosis is a form of cell death characterized by phospholipid peroxidation, where numerous studies have suggested that the induction of ferroptosis is a therapeutic strategy to target therapy refractory cancer entities. Ferroptosis suppressor protein 1 (FSP1), an NAD(P)H-ubiquinone reductase, is a key determinant of ferroptosis vulnerability, and its pharmacological inhibition was shown to strongly sensitize cancer cells to ferroptosis. A first generation of FSP1 inhibitors, exemplified by the small molecule iFSP1, has been reported; however, the molecular mechanisms underlying inhibition have not been characterized in detail. In this study, we explore the species-specific inhibition of iFSP1 on the human isoform to gain insights into its mechanism of action. Using a combination of cellular, biochemical, and computational methods, we establish a critical contribution of a species-specific aromatic architecture that is essential for target engagement. The results described here provide valuable insights for the rational development of second-generation FSP1 inhibitors combined with a tracer for screening the druggable pocket. In addition, we pose a cautionary notice for using iFSP1 in animal models, specifically murine models.</jats:p>
  • Zugangsstatus: Freier Zugang